{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:07Z","timestamp":1792784887548,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas grant 2023\/GNT2030541"],"award-info":[{"award-number":["Ideas grant 2023\/GNT2030541"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas grant 2021\/GNT2013180"],"award-info":[{"award-number":["Ideas grant 2021\/GNT2013180"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas grant 2023\/GNT2030541"],"award-info":[{"award-number":["Ideas grant 2023\/GNT2030541"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas grant 2021\/GNT2013180"],"award-info":[{"award-number":["Ideas grant 2021\/GNT2013180"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas grant 2023\/GNT2030541"],"award-info":[{"award-number":["Ideas grant 2023\/GNT2030541"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001039","name":"Neurosurgical Research Foundation","doi-asserted-by":"publisher","award":["Chris Adams award"],"award-info":[{"award-number":["Chris Adams award"]}],"id":[{"id":"10.13039\/501100001039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["365022"],"award-info":[{"award-number":["365022"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["Cooperatio Program, research area \u2018Oncology and Haematology"],"award-info":[{"award-number":["Cooperatio Program, research area \u2018Oncology and Haematology"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tour de Cure Grants, The Mark Hughes Foundation","id":[{"id":"https:\/\/ror.org\/05988s291","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006641","name":"Cure Brain Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001220","name":"Medical Advances Without Animals Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001220","id-type":"DOI","asserted-by":"publisher"}]},{"name":"McCleary Murchland Fellowship, Charlie Teo Foundation, Tour de Cure Grants","id":[{"id":"https:\/\/ror.org\/056q84j13","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EXCELES, ID Project No. LX22NPO5102"],"award-info":[{"award-number":["EXCELES, ID Project No. LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EATRIS-CZ (LM2023053)"],"award-info":[{"award-number":["EATRIS-CZ (LM2023053)"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["\u2018Center for Tumor ecology\u2019 (reg. n. CZ.02.1.01\/0.0\/0.0\/16_019\/0000785)"],"award-info":[{"award-number":["\u2018Center for Tumor ecology\u2019 (reg. n. CZ.02.1.01\/0.0\/0.0\/16_019\/0000785)"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) is a highly aggressive primary brain tumor characterized by profound immunosuppression that facilitates tumor progression and promotes therapeutic resistance. Fibroblast activation protein (FAP), a recognized theranostic target in multiple cancers, is upregulated in GBM and predominantly expressed by pericyte-like stromal cells. Here we identify a role for FAP\u207a pericyte-like cells in shaping the GBM immune microenvironment through monocyte recruitment and differentiation. Analysis of The Cancer Genome Atlas (TCGA) datasets, supported by reverse-transcription quantitative PCR and immunohistochemistry, revealed that elevated FAP expression\u2014serving as a proxy for the abundance of FAP\u207a pericyte-like cells\u2014is associated with an immune-enriched tumor microenvironment characterized by higher macrophage abundance and elevated expression of M2 polarization markers. Spatial analyses, including immunofluorescence and spatial transcriptomics, demonstrated that immunosuppressive macrophages preferentially localize in proximity to FAP\u207a pericytes. Single-cell RNA sequencing identified these FAP\u207a cells as a distinct perivascular stromal subset with a unique expression pattern of extracellular matrix components and cytokines, including CCL2 and CSF1, with corresponding receptors expressed on myeloid cells. Functional assays using patient-derived FAP\u207a pericyte-like cells confirmed their ability to attract monocytes via soluble mediators and to promote their differentiation and polarization into tumor-associated macrophages with immunoregulatory features, partly mediated by the CSF1\u2013CSF1R axis. Orthotopic co-implantation experiments in mice further supported their capacity to enhance myeloid infiltration in vivo. Consistent with these biological effects, a transcriptional signature characteristic of FAP\u207a pericytes correlated with worse overall survival in patients with GBM. Together, these findings position FAP\u207a pericyte-like cells as modulators of the GBM immune landscape, fostering a tumor-permissive niche by promoting the differentiation of circulating monocytes into immunoregulatory macrophages. Targeting this stromal population may offer new therapeutic avenues to reprogram tumor-associated immune responses in GBM.<\/jats:p>","DOI":"10.1038\/s12276-026-01827-8","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:53:27Z","timestamp":1789095207000},"page":"3177-3195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-2493","authenticated-orcid":false,"given":"Magdalena","family":"Houdova Megova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-9269","authenticated-orcid":false,"given":"Chloe","family":"Shard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Vymolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Ternerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Svablova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0878-4882","authenticated-orcid":false,"given":"Tomas","family":"Buna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Straka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdislava","family":"Vanickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evzen","family":"Krepela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Kupcova Skalnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-1525","authenticated-orcid":false,"given":"Michal","family":"Kolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Sachova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6446-9797","authenticated-orcid":false,"given":"Jan","family":"Kubovciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Balaziova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Vymola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Hrabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-9666","authenticated-orcid":false,"given":"Lisa M.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3353-1970","authenticated-orcid":false,"given":"Ashwini","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Netuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo A.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2158-4837","authenticated-orcid":false,"given":"Petr","family":"Busek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3247-5436","authenticated-orcid":false,"given":"Aleksi","family":"Sedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"1827_CR1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3389\/fimmu.2020.01402","volume":"11","author":"S DeCordova","year":"2020","unstructured":"DeCordova, S. et al. Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma. Front. Immunol. 11, 1402 (2020).","journal-title":"Front. Immunol."},{"key":"1827_CR2","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm, F. et al. Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell 181, 1643\u20131660 (2020).","journal-title":"Cell"},{"key":"1827_CR3","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","volume":"181","author":"E Friebel","year":"2020","unstructured":"Friebel, E. et al. Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes. Cell 181, 1626\u20131642 (2020).","journal-title":"Cell"},{"key":"1827_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-021-00906-x","volume":"13","author":"AX Chen","year":"2021","unstructured":"Chen, A. X. et al. Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker. Genome Med. 13, 1\u201313 (2021).","journal-title":"Genome Med."},{"key":"1827_CR5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.20517\/2347-8659.2018.42","volume":"5","author":"C Russo Dello","year":"2018","unstructured":"Russo Dello, C. & Cappoli, N. Glioma associated microglia\/macrophages, a potential pharmacological target to promote antitumor inflammatory immune response in the treatment of glioblastoma. Neuroimmunol. Neuroinflamm. 5, 36 (2018).","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"1827_CR6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2326-6066.CIR-23-0211","volume":"12","author":"X Ran","year":"2024","unstructured":"Ran, X. et al. Single-cell transcriptomics reveals the heterogeneity of the immune landscape of IDH\u2013wild-type high-grade gliomas. Cancer Immunol. Res. 12, 232\u2013246 (2024).","journal-title":"Cancer Immunol. Res."},{"key":"1827_CR7","doi-asserted-by":"crossref","first-page":"113343","DOI":"10.1016\/j.biopha.2022.113343","volume":"153","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. New insights from the single-cell level: tumor associated macrophages heterogeneity and personalized therapy. Biomed. Pharmacother. 153, 113343 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1827_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1362-4","volume":"18","author":"S M\u00fcller","year":"2017","unstructured":"M\u00fcller, S. et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol. 18, 1\u201314 (2017).","journal-title":"Genome Biol."},{"key":"1827_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1827_CR10","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9, E. & Blomberg, R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene 37, 4343\u20134357 (2018).","journal-title":"Oncogene"},{"key":"1827_CR11","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2741\/4682","volume":"23","author":"P Busek","year":"2018","unstructured":"Busek, P., Mateu-Sanz, R., Zubal, M., Kotackova, L. & Sedo, A. Targeting fibroblast activation protein in cancer - Prospects and caveats. Front. Biosci. 23, 1933\u20131968 (2018).","journal-title":"Front. Biosci."},{"key":"1827_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen, X. & Song, E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat. Rev. Drug Discov. 18, 99\u2013115 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1827_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.coi.2020.03.004","volume":"64","author":"R Barrett","year":"2020","unstructured":"Barrett, R. & Pur\u00e9, E. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy. Curr. Opin. Immunol. 64, 80\u201387, https:\/\/doi.org\/10.1016\/j.coi.2020.03.004 (2020).","journal-title":"Curr. Opin. Immunol."},{"key":"1827_CR14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail, D. F. & Joyce, J. A. The microenvironmental landscape of brain tumors. Cancer Cell 31, 326\u2013341 (2017).","journal-title":"Cancer Cell"},{"key":"1827_CR15","doi-asserted-by":"crossref","unstructured":"Ebert, L. M. et al. Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy. Clin. Transl. Immunol. 9, e1191 (2020).","DOI":"10.1002\/cti2.1191"},{"key":"1827_CR16","doi-asserted-by":"crossref","first-page":"13961","DOI":"10.1007\/s13277-016-5274-9","volume":"37","author":"P Busek","year":"2016","unstructured":"Busek, P. et al. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma. Tumour Biol. 37, 13961\u201313971 (2016).","journal-title":"Tumour Biol."},{"key":"1827_CR17","doi-asserted-by":"crossref","unstructured":"Jain, S. et al. Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects. J. Clin. Invest. 133, e147087 (2023).","DOI":"10.1172\/JCI147087"},{"key":"1827_CR18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1126\/science.aaf2666","volume":"360","author":"RB Puchalski","year":"2018","unstructured":"Puchalski, R. B. et al. An anatomic transcriptional atlas of human glioblastoma. Science 360, 660\u2013663 (2018).","journal-title":"Science"},{"key":"1827_CR19","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.3390\/cancers13133304","volume":"13","author":"E Balaziova","year":"2021","unstructured":"Balaziova, E. et al. Fibroblast activation protein expressing mesenchymal cells promote glioblastoma angiogenesis. Cancers 13, 3304 (2021).","journal-title":"Cancers"},{"key":"1827_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/neuonc\/now247","volume":"19","author":"RL Bowman","year":"2017","unstructured":"Bowman, R. L., Wang, Q., Carro, A., Verhaak, R. G. W. & Squatrito, M. GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro. Oncol. 19, 139\u2013141 (2017).","journal-title":"Neuro. Oncol."},{"key":"1827_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"1827_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1827_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"1827_CR24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"1827_CR25","doi-asserted-by":"crossref","first-page":"D682","DOI":"10.1093\/nar\/gkz1138","volume":"48","author":"AD Yates","year":"2020","unstructured":"Yates, A. D. et al. Ensembl 2020. Nucleic Acids Res. 48, D682\u2013D688 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1827_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"1827_CR27","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"1827_CR28","first-page":"36","volume":"11","author":"M Abr\u00e0moff","year":"2004","unstructured":"Abr\u00e0moff, M., Magalh\u00e3es, P. J. & Ram, S. Image processing with ImageJ. Biophotonics Int. 11, 36\u201342 (2004).","journal-title":"Biophotonics Int."},{"key":"1827_CR29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccell.2022.02.016","volume":"40","author":"VG LeBlanc","year":"2022","unstructured":"LeBlanc, V. G. et al. Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity. Cancer Cell 40, 379\u2013392 (2022).","journal-title":"Cancer Cell"},{"key":"1827_CR30","doi-asserted-by":"crossref","unstructured":"Abdelfattah, N. et al. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat. Commun. 13, 767 (2022).","DOI":"10.1038\/s41467-022-28372-y"},{"key":"1827_CR31","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-025-02167-5","volume":"57","author":"M Nomura","year":"2025","unstructured":"Nomura, M. et al. The multilayered transcriptional architecture of glioblastoma ecosystems. Nat. Genet. 57, 1155\u20131167 (2025).","journal-title":"Nat. Genet."},{"key":"1827_CR32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.immuni.2025.02.022","volume":"58","author":"L Bejarano","year":"2025","unstructured":"Bejarano, L. et al. Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors. Immunity 58, 1015\u20131032 (2025).","journal-title":"Immunity"},{"key":"1827_CR33","doi-asserted-by":"crossref","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","DOI":"10.1038\/s41467-021-21246-9"},{"key":"1827_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","volume":"24","author":"AR Pombo Antunes","year":"2021","unstructured":"Pombo Antunes, A. R. et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat. Neurosci. 24, 595\u2013610 (2021).","journal-title":"Nat. Neurosci."},{"key":"1827_CR35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677\u2013686 (2004).","journal-title":"Trends Immunol."},{"key":"1827_CR36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","volume":"40","author":"VM Ravi","year":"2022","unstructured":"Ravi, V. M. et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell 40, 639\u2013655 (2022).","journal-title":"Cancer Cell"},{"key":"1827_CR37","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","volume":"187","author":"AC Greenwald","year":"2024","unstructured":"Greenwald, A. C. et al. Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell 187, 2485\u20132501 (2024).","journal-title":"Cell"},{"key":"1827_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2021","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol. 40, 517\u2013526 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1827_CR39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel, C. et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178, 835\u2013849 (2019).","journal-title":"Cell"},{"key":"1827_CR40","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley, D. et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat. Genet. 54, 1192 (2022).","journal-title":"Nat. Genet."},{"key":"1827_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-20929-6","volume":"8","author":"J Sana","year":"2018","unstructured":"Sana, J. et al. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Sci. Rep. 8, 1\u201311 (2018).","journal-title":"Sci. Rep."},{"key":"1827_CR42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-4939-0320-7_31","volume":"1135","author":"A Boroujerdi","year":"2014","unstructured":"Boroujerdi, A., Tigges, U., Welser-Alves, J. V. & Milner, R. Isolation and culture of primary pericytes from mouse brain. Methods Mol. Biol. 1135, 383\u2013392 (2014).","journal-title":"Methods Mol. Biol."},{"key":"1827_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22031046","volume":"22","author":"E Krepela","year":"2021","unstructured":"Krepela, E. et al. Regulation of fibroblast activation protein by transforming growth factor beta-1 in glioblastoma microenvironment. Int. J. Mol. Sci. 22, 1\u201320 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1827_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-021-01156-z","volume":"9","author":"A Buonfiglioli","year":"2021","unstructured":"Buonfiglioli, A. & Hambardzumyan, D. Macrophages and microglia: the cerberus of glioblastoma. Acta Neuropathol. Commun. 9, 1\u201321 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"1827_CR45","doi-asserted-by":"crossref","unstructured":"Vymola, P. et al. Fibrillar extracellular matrix produced by pericyte-like cells facilitates glioma cell dissemination. Brain Pathol. 34, e13265 (2024).","DOI":"10.1111\/bpa.13265"},{"key":"1827_CR46","doi-asserted-by":"crossref","unstructured":"Li, M. et al. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma. Acta Neuropathol. Commun. 8, 221 (2020).","DOI":"10.1186\/s40478-020-01096-0"},{"key":"1827_CR47","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/cns.14024","volume":"29","author":"Y Miao","year":"2023","unstructured":"Miao, Y. et al. Anti-cancer effect of targeting fibroblast activation protein alpha in glioblastoma through remodeling macrophage phenotype and suppressing tumor progression. CNS Neurosci. Ther. 29, 878 (2023).","journal-title":"CNS Neurosci. Ther."},{"key":"1827_CR48","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3023622\/v1","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Single-cell transcriptomic analysis reveals the functional heterogeneity and clinical signification of pericyte subpopulations in gliomas. Preprint at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-3023622\/v1 (2023).","journal-title":"Research Square"},{"key":"1827_CR49","doi-asserted-by":"crossref","unstructured":"Zarodniuk, M., Steele, A., Lu, X., Li, J. & Datta, M. CNS tumor stroma transcriptomics identify perivascular fibroblasts as predictors of immunotherapy resistance in glioblastoma patients. NPJ Genom Med. 8, 35 (2023).","DOI":"10.1038\/s41525-023-00381-w"},{"key":"1827_CR50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/cmi.2017.135","volume":"15","author":"T Yoshimura","year":"2018","unstructured":"Yoshimura, T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell. Mol. Immunol. 15, 335 (2018).","journal-title":"Mol. Immunol."},{"key":"1827_CR51","doi-asserted-by":"crossref","unstructured":"Hu, J. et al. Regulation of tumor immune suppression and cancer cell survival by CXCL1\/2 elevation in glioblastoma multiforme. Sci. Adv. 7, eabc2511 (2021).","DOI":"10.1126\/sciadv.abc2511"},{"key":"1827_CR52","doi-asserted-by":"crossref","first-page":"1067641","DOI":"10.3389\/fimmu.2023.1067641","volume":"14","author":"X Zhou","year":"2023","unstructured":"Zhou, X., Jin, G., Zhang, J. & Liu, F. Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment. Front. Immunol. 14, 1067641 (2023).","journal-title":"Front. Immunol."},{"key":"1827_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi, J. et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. Nat. Commun. 13, 1\u201320 (2022).","journal-title":"Nat. Commun."},{"key":"1827_CR54","doi-asserted-by":"crossref","unstructured":"Liu, R. et al. SEMA3C regulates tumor-associated macrophage phenotype and influences lung cancer cell migration and invasion through VNN1. Hum. Exp. Toxicol. 44, 9603271251376577 (2025).","DOI":"10.1177\/09603271251376577"},{"key":"1827_CR55","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.celrep.2018.10.082","volume":"25","author":"MH Kubala","year":"2018","unstructured":"Kubala, M. H. et al. Plasminogen activator inhibitor-1 promotes the recruitment and polarization of macrophages in cancer. Cell Rep. 25, 2177 (2018).","journal-title":"Cell Rep."},{"key":"1827_CR56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","volume":"74","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut 74, 350\u2013363 (2025).","journal-title":"Gut"},{"key":"1827_CR57","doi-asserted-by":"crossref","first-page":"113599","DOI":"10.1016\/j.biopha.2022.113599","volume":"155","author":"MLP Bueno","year":"2022","unstructured":"Bueno, M. L. P., Saad, S. T. O. & Roversi, F. M. WNT5A in tumor development and progression: a comprehensive review. Biomed. Pharmacother. 155, 113599 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1827_CR58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coi.2020.03.009","volume":"64","author":"A Benabid","year":"2020","unstructured":"Benabid, A. & Peduto, L. Mesenchymal perivascular cells in immunity and disease. Curr. Opin. Immunol. 64, 50\u201355 (2020).","journal-title":"Curr. Opin. Immunol."},{"key":"1827_CR59","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s44321-025-00222-6","volume":"17","author":"B He","year":"2025","unstructured":"He, B. et al. Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity. EMBO Mol. Med. 17, 1071\u20131100 (2025).","journal-title":"EMBO Mol. Med."},{"key":"1827_CR60","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.7150\/ijbs.113325","volume":"21","author":"X Lei","year":"2025","unstructured":"Lei, X. et al. Targeting the NAT10\/XIST\/YAP1 axis-mediated vascular abnormalization enhances immune checkpoint blockade in gastric cancer. Int. J. Biol. Sci. 21, 4997\u20135014 (2025).","journal-title":"Int. J. Biol. Sci."},{"key":"1827_CR61","doi-asserted-by":"crossref","unstructured":"Li, Z.-J. et al. Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models. J. Clin. Invest. 134, e179860 (2024).","DOI":"10.1172\/JCI179860"},{"key":"1827_CR62","first-page":"1","volume":"1","author":"DM Longo","year":"2012","unstructured":"Longo, D. M. et al. Inter-donor variation in cell subset specific immune signaling responses in healthy individuals. Am. J. Clin. Exp. Immunol. 1, 1 (2012).","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"1827_CR63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jim.2009.10.010","volume":"352","author":"T Wisniewski","year":"2010","unstructured":"Wisniewski, T. et al. Assessment of chemokine receptor function on monocytes in whole blood: in vitro and ex vivo evaluations of a CCR2 antagonist. J. Immunol. Methods 352, 101\u2013110 (2010).","journal-title":"J. Immunol. Methods"},{"key":"1827_CR64","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.4049\/jimmunol.161.12.6896","volume":"161","author":"JM Weiss","year":"1998","unstructured":"Weiss, J. M., Downie, S. A., Lyman, W. D. & Berman, J. W. Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood\u2013brain barrier. J. Immunol. 161, 6896\u20136903 (1998).","journal-title":"J. Immunol."},{"key":"1827_CR65","doi-asserted-by":"crossref","first-page":"20655","DOI":"10.1073\/pnas.1903542116","volume":"116","author":"R Valdor","year":"2019","unstructured":"Valdor, R. et al. Glioblastoma ablates pericytes antitumor immune function through aberrant up-regulation of chaperone-mediated autophagy. Proc. Natl Acad. Sci. USA 116, 20655\u201320665 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1827_CR66","doi-asserted-by":"crossref","unstructured":"Braun, S. et al. Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma. Nat. Commun. 16, 10918 (2025).","DOI":"10.1038\/s41467-025-66985-1"},{"key":"1827_CR67","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/0008-5472.CAN-16-2310","volume":"77","author":"Z Chen","year":"2017","unstructured":"Chen, Z. et al. Cellular and molecular identity of tumor-associated macrophages in glioblastoma. Cancer Res. 77, 2266\u20132278 (2017).","journal-title":"Cancer Res."},{"key":"1827_CR68","doi-asserted-by":"crossref","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","volume":"113","author":"K Hosaka","year":"2016","unstructured":"Hosaka, K. et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc. Natl Acad. Sci. USA 113, E5618\u2013E5627 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1827_CR69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jlb.67.1.97","volume":"67","author":"C Buechler","year":"2000","unstructured":"Buechler, C. et al. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukoc. Biol. 67, 97\u2013103 (2000).","journal-title":"J. Leukoc. Biol."},{"key":"1827_CR70","first-page":"100041","volume":"12","author":"OR Mahon","year":"2021","unstructured":"Mahon, O. R. et al. Extracellular matrix scaffolds derived from different musculoskeletal tissues drive distinct macrophage phenotypes and direct tissue-specific cellular differentiation. J. Immunol. Regen. Med. 12, 100041 (2021).","journal-title":"J. Immunol. Regen. Med."},{"key":"1827_CR71","doi-asserted-by":"crossref","unstructured":"Chen, A. et al. Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma. J. Clin. Invest. 131, e147552 (2021).","DOI":"10.1172\/JCI147552"},{"key":"1827_CR72","doi-asserted-by":"crossref","first-page":"80521","DOI":"10.18632\/oncotarget.11825","volume":"7","author":"X Guo","year":"2016","unstructured":"Guo, X. et al. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR. Oncotarget 7, 80521\u201380542 (2016).","journal-title":"Oncotarget"},{"key":"1827_CR73","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/82763","volume":"1","author":"P Chomarat","year":"2000","unstructured":"Chomarat, P., Banchereau, J., Davoust, J. & Palucka, A. K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1, 510\u2013514 (2000).","journal-title":"Nat. Immunol."},{"key":"1827_CR74","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41422-021-00528-3","volume":"31","author":"XN Zhang","year":"2021","unstructured":"Zhang, X. N. et al. Pericytes augment glioblastoma cell resistance to temozolomide through CCL5\u2013CCR5 paracrine signaling. Cell Res. 31, 1072\u20131087 (2021).","journal-title":"Cell Res."},{"key":"1827_CR75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1878-0261.13016","volume":"16","author":"C Oudenaarden","year":"2022","unstructured":"Oudenaarden, C., Sj\u00f6lund, J. & Pietras, K. Upregulated functional gene expression programmes in tumour pericytes mark progression in patients with low-grade glioma. Mol. Oncol. 16, 405\u2013421 (2022).","journal-title":"Mol. Oncol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01827-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:02:21Z","timestamp":1790967741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01827-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":75,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01827-8","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.P. is the founder and CEO of Combinatics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors report there are no competing interests to declare except for A.P. who is the founder and CEO of Combinatics.","order":2,"name":"Ethics","label":"Disclousure statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}